Suppr超能文献

一些新型丙酮酸衍生物的合成及其抗结核作用

Synthesis and antituberculosis action of some new pyruvic acid derivatives.

作者信息

Ungureanu Margareta, Diculencu Daniela, Archip Cristina

机构信息

Scholl of Medical Bioengineering, "Gr.T. Popa" University of Medicine and Pharmacy Iaşi.

出版信息

Rev Med Chir Soc Med Nat Iasi. 2008 Jul-Sep;112(3):860-4.

Abstract

UNLABELLED

The present paper studies the synthesis and activity of 12 new azoic derivatives against Mycobacterium tuberculosis.

MATERIAL AND METHOD

In order to obtain new antituberculosis substances, we studied 6 thiadiazolic derivatives and 6 triazolic derivatives of pyruvic acid and we observed the influence of the different radical groups inserted in the molecule on their antituberculosis activity. For this study we developed a simple method to obtain the new derivatives. The first stage of the experiment was the synthesis of the thyosemicarbazide derivatives. In order to obtain the thiadiazolic derivatives we treated the thyosemicarbazides with concentrated sulfuric acid. The triazolic derivatives were obtained after treating the thiosemicarbazide derivatives with a diluted NaOH solution at boiling.

RESULTS

The structure of the substances was furthermore confirmed by IR and quantitative elemental analysis. The newly obtained substances were tested on the Mycobacterium tuberculosis complex, 6 concentrations for each substance. Early tests on Mycobacterium tuberculosis indicate that 2 of the tested substances have clear antituberculosis activity in vitro for the tested concentrations. For the other tested substances further research is needed since the CMI hasn't been reached in their cas.

CONCLUSIONS

We synthesised 12 new thiadiazolic and triazolic derivatives in order to obtain new possible antituberculosis agents. Early tests on Mycobacterium tuberculosis indicate that 2 of the tested substances have clear antituberculosis activity in vitro for the tested concentrations.

摘要

未标注

本文研究了12种新型偶氮衍生物对结核分枝杆菌的合成及活性。

材料与方法

为了获得新型抗结核物质,我们研究了丙酮酸的6种噻二唑衍生物和6种三唑衍生物,并观察了分子中插入的不同基团对其抗结核活性的影响。为进行此项研究,我们开发了一种简单方法来获得新型衍生物。实验的第一阶段是合成硫代氨基脲衍生物。为了获得噻二唑衍生物,我们用浓硫酸处理硫代氨基脲。用稀释的氢氧化钠溶液在沸腾条件下处理硫代氨基脲衍生物后得到三唑衍生物。

结果

通过红外光谱和定量元素分析进一步证实了这些物质的结构。对新获得的物质在结核分枝杆菌复合体上进行了测试,每种物质设6个浓度。对结核分枝杆菌的早期测试表明,在所测试的浓度下,有2种受试物质在体外具有明确的抗结核活性。对于其他受试物质,由于尚未达到临界最小抑菌浓度,因此需要进一步研究。

结论

我们合成了12种新型噻二唑和三唑衍生物,以获得新型潜在抗结核药物。对结核分枝杆菌的早期测试表明,在所测试的浓度下,有2种受试物质在体外具有明确的抗结核活性。

相似文献

1
Synthesis and antituberculosis action of some new pyruvic acid derivatives.
Rev Med Chir Soc Med Nat Iasi. 2008 Jul-Sep;112(3):860-4.
3
Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies.
Eur J Med Chem. 2011 Oct;46(10):4897-903. doi: 10.1016/j.ejmech.2011.07.046. Epub 2011 Aug 3.
4
Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents.
Bioorg Med Chem Lett. 2012 Mar 1;22(5):1917-21. doi: 10.1016/j.bmcl.2012.01.052. Epub 2012 Jan 26.
5
Synthesis and evaluation of antitubercular activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives.
Bioorg Med Chem. 2006 May 1;14(9):3069-80. doi: 10.1016/j.bmc.2005.12.020. Epub 2006 Jan 6.
7
Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Eur J Med Chem. 2011 Nov;46(11):5524-31. doi: 10.1016/j.ejmech.2011.09.013. Epub 2011 Sep 16.
8
Synthesis of novel [1,2]-diamines with antituberculosis activity.
Bioorg Med Chem Lett. 2009 Sep 15;19(18):5372-5. doi: 10.1016/j.bmcl.2009.07.126. Epub 2009 Aug 6.
10
Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis.
Bioorg Med Chem Lett. 2011 Dec 15;21(24):7273-6. doi: 10.1016/j.bmcl.2011.10.048. Epub 2011 Oct 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验